Evidence map›Paper›PMID 35748914›Full record

ArticleCell cycle (Georgetown, Tex.)2022

MiR-4268 suppresses gastric cancer genesis through inhibiting keratin 80.

Fan Zhang, Guoxian Wang, Wenjuan Yan, Hongmei Jiang

Open access · greenAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Fan ZhangDepartment of Gastroenterology, Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
Guoxian WangDepartment of Radiology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei, China.
Wenjuan YanDepartment of Gastroenterology, The Third People's Hospital of Hubei Province, Wuhan, Hubei, China.
Hongmei JiangDepartment of Gastroenterology, Wuhan Third Hospital, Tongren Hospital of Wuhan University (Optics Valley Area), Wuhan, Hubei, China.
Hubei Zhongshan Hospital · CNTongren Hospital · CNWuhan Third Hospital · CNWuhan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) affects a large proportion of cancer patients worldwide, and the prediction of potential biomarkers can greatly improve its diagnosis and treatment. Here, miR-4268 and keratin 80 (KRT80) expression in GC tissues and cell lines was determined. The effect of downregulating miR-4268 and interfering with KRT80 expression on the viability, proliferation, apoptosis, and migration of GC cells were evaluated. The interaction between miR-4268 and KRT80 was studied using luciferase reporter and RNA pull-down assays. The western blot, CCK-8, BrdU, caspase-3 activity, Transwell assays were performed for the functional characterization. In GC tissues and cells, KRT80 expression was found to be significantly higher, while that of miR-4268 was significantly lower than the respective expressions in normal tissues and cells. Interference with KRT80 expression inhibited the viability, proliferation, and migration of GC cells and facilitated cell apoptosis

Indexed as

MicroRNAsStomach NeoplasmsCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansKeratinsKeratins, Type IIPhosphatidylinositol 3-KinasesKeratinsKeratins, Type IIKRT80 protein, humanMicroRNAsPhosphatidylinositol 3-KinasesapoptosisGastric cancerKRT80miR-4268proliferation

Identifiers

PMID35748914
PMCPMC9467563
OpenAlexW4283390545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.